Integrating nanotechnology with bio-inspired techniques, we are developing transformative nano-biomaterials and devices. Our technologies address global challenges in human health such as food safety, point of care diagnostics, therapeutics and infectious diseases.

Dr. Tohid Didar holds Canada Research Chair (CRC) in NanoBiomaterials and is an Associate Professor in the Department of Mechanical Engineering, School of Biomedical Engineering and a member of the Institute for Infectious Disease Research (IIDR) at McMaster University.

Our lab’s vision is to design, develop and translate to society transformative nanobiomaterials and devices that address global challenges in food safety, antimicrobial resistance and human health. We focus on advancing the understanding of interactions between living and synthetic matter.

Before joining McMaster University in 2016, Dr. Tohid Didar was a postdoctoral fellow at the Wyss Institute for Biologically Inspired Engineering at Harvard University. There he designed and developed a robust and clinically relevant extracorporeal dialysis-like treatment (DLT) device for sepsis treatment, leveraging medical grade hollow fiber ...

Lab on a Chip 12, 3249-3266, 2012. 590: ... TF Didar. Acs Nano 13 (8), 8517-8536, 2019. 415: 2019: Antimicrobial nanomaterials and coatings: current mechanisms and future perspectives to control the spread of viruses including SARS-CoV-2. SM Imani, L Ladouceur, T Marshall, R Maclachlan, L Soleymani, TF Didar.

Tohid Didar is developing the next generation of biomaterials, biosensors and medical coatings. He plans on implementing bio-functional interfaces in the forms of large-scale microfluidic systems for developing new diagnostics, drug discovery and personalized medicine platforms that will innovate different aspects of our aging world.

Give us a follow to stay updated with the worlds Bio-Inspired technologies and McMaster's Bio-inspired Engineering Lab 🔬🌿 - Posts by Didar lab members

Before joining McMaster University in 2016, Dr. Tohid Didar was a postdoctoral fellow at the Wyss Institute for Biologically Inspired Engineering at Harvard University. There he designed and developed a robust and clinically relevant extracorporeal dialysis-like treatment (DLT) device for sepsis treatment, leveraging medical grade hollow fiber ...

Dr. Didar has also co-founded FendX (a McMaster spin off) to commercialize pathogen repellant and antimicrobial coatings developed in his lab. Dr. Didar has published over 50 journal papers, over 12 patent applications and has presented over 30 national and international invited talks and keynote speeches.